Y-27632 dihydrochloride
Contact us: [email protected]
 Y-27632 dihydrochloride |
|
A3008-200 |
ApexBio |
200 mg |
EUR 704 |
|
|
|
Description: Cell Cycle/Checkpoint|ROCK#TGF-β / Smad Signaling|ROCK |
Y-27632 dihydrochloride |
|
A3008-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 68 |
|
|
|
Description: Cell Cycle/Checkpoint|ROCK#TGF-β / Smad Signaling|ROCK |
Y-27632 dihydrochloride |
|
A3008-50 |
ApexBio |
50 mg |
EUR 256 |
|
|
|
Description: Cell Cycle/Checkpoint|ROCK#TGF-β / Smad Signaling|ROCK |
) Y-27632 (dihydrochloride) |
|
HY-10583 |
MedChemExpress |
50mg |
EUR 1244.61 |
|
Description: Y-27632 dihydrochloride is an orally active and ATP-competitive ROCK (Rho-kinase) inhibitor (ROCK-I Ki=220 nM; ROCK-II Ki=300 nM). Y-27632 dihydrochloride shows antiepileptic effects[1][2][3][4]. |
Y-27632 dihydrochloride |
|
MBS577605-100mg |
MyBiosource |
100mg |
EUR 335 |
Y-27632 dihydrochloride |
|
MBS577605-10mg |
MyBiosource |
10mg |
EUR 150 |
Y-27632 dihydrochloride |
|
MBS577605-25mg |
MyBiosource |
25mg |
EUR 190 |
Y-27632 dihydrochloride |
|
MBS577605-50mg |
MyBiosource |
50mg |
EUR 240 |
Y-27632 dihydrochloride |
|
MBS577605-5mg |
MyBiosource |
5mg |
EUR 145 |
Y-27632 dihydrochloride |
|
MBS3601202-100mg |
MyBiosource |
100mg |
EUR 400 |
Y-27632 dihydrochloride |
|
MBS3601202-10mg |
MyBiosource |
10mg |
EUR 215 |
Y-27632 dihydrochloride |
|
MBS3601202-25mg |
MyBiosource |
25mg |
EUR 250 |
Y-27632 dihydrochloride |
|
MBS3601202-50mg |
MyBiosource |
50mg |
EUR 310 |
Y-27632 dihydrochloride |
|
MBS3601202-5mg |
MyBiosource |
5mg |
EUR 200 |
 Y-27632 Dihydrochloride |
|
MBS696282-10mg |
MyBiosource |
10mg |
EUR 280 |
Y-27632 Dihydrochloride |
|
MBS696282-1mg |
MyBiosource |
1mg |
EUR 155 |
Y-27632 Dihydrochloride |
|
MBS696282-50mg |
MyBiosource |
50mg |
EUR 765 |
Y-27632 Dihydrochloride |
|
MBS696282-5x50mg |
MyBiosource |
5x50mg |
EUR 3405 |
Y-27632 dihydrochloride |
|
T1725-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Y-27632 dihydrochloride |
Y-27632 dihydrochloride |
|
T1725-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
|
|
Description: Y-27632 dihydrochloride |
Y-27632 dihydrochloride |
|
T1725-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Y-27632 dihydrochloride |
Y-27632 dihydrochloride |
|
T1725-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Y-27632 dihydrochloride |
Y-27632 dihydrochloride |
|
T1725-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Y-27632 dihydrochloride |
 (GMP)) Y-27632 (dihydrochloride) (GMP) |
|
HY-10583G |
MedChemExpress |
10 mg |
EUR 3896.16 |
|
Description: Y-27632 dihydrochloride (GMP) is the GMP level of Y-27632 dihydrochloride (HY-10583). GMP guidelines are used to produce Y-27632 dihydrochloride (GMP). GMP small molecules works appropriately as an auxiliary reagent for cell research manufacture. Y-27632 dihydrochloride is an orally active and ATP-competitive ROCK (Rho-kinase) inhibitor with antiepileptic effect[1][2][3][4]. |
 Y-27632-d4 Dihydrochloride Hydrate |
|
MBS6053346-1mg |
MyBiosource |
1(mg |
EUR 580 |
Y-27632-d4 Dihydrochloride Hydrate |
|
MBS6053346-5x1mg |
MyBiosource |
5x1mg |
EUR 2470 |
 Y-27632, Dihydrochloride Salt [CAS# 129830-38-2] |
|
Y-5301 |
LC LABORATORIES |
5 mg |
EUR 37 |
 Y-39983 dihydrochloride |
|
B1176-10 |
ApexBio |
10 mg |
EUR 135.2 |
|
|
|
Description: Cell Cycle/Checkpoint|ROCK#TGF-β / Smad Signaling|ROCK |
Y-39983 dihydrochloride |
|
B1176-100 |
ApexBio |
100 mg |
EUR 2881.2 |
|
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1]. |
Y-39983 dihydrochloride |
|
B1176-2 |
ApexBio |
2mg |
EUR 131.2 |
|
|
|
Description: Cell Cycle/Checkpoint|ROCK#TGF-β / Smad Signaling|ROCK |
Y-39983 dihydrochloride |
|
B1176-5 |
ApexBio |
5 mg |
EUR 80 |
|
|
|
Description: Cell Cycle/Checkpoint|ROCK#TGF-β / Smad Signaling|ROCK |
Y-27632 dihydrochloride
